The 2022 American Society of Hematology (ASH) Annual Meeting was held in New Orleans, Louisiana from December 10-13, 2022. Conference highlights include:

• Final results from the Phase III ALPINE study of Brukinsa vs. Imbruvica in r/r CLL/SLL
• Updated data from the FL and DLBCL cohorts of odronextamab’s Phase II ELM study
• Top-line results from the Phase III TRIANGLE study of Imbruvica in the 1^st line for MCL
• Top-line results from the Phase II proof-of-concept study for vemircopan for PNH

This post-meeting report features commentary from our analysts on specific presentations. It also includes a compilation of all data events added in conjunction with the meeting.

For the full report, download the PDF version at the top of the page. A full list of ASH events is also available for download as an Excel file.

Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.

For our disclosures, please read the Biomedtracker Research Standards.